Jose Darocha Acquires 86,000 Shares of Crescita Therapeutics Inc. (TSE:CTX) Stock

Crescita Therapeutics Inc. (TSE:CTX) Director Jose Darocha purchased 86,000 shares of the firm’s stock in a transaction dated Friday, December 27th. The shares were bought at an average cost of C$0.60 per share, for a total transaction of C$51,436.60.

Crescita Therapeutics Stock Up 7.1 %

TSE:CTX opened at C$0.60 on Monday. The company has a market cap of C$11.63 million, a price-to-earnings ratio of -4.00 and a beta of 1.69. The company has a debt-to-equity ratio of 6.02, a quick ratio of 2.29 and a current ratio of 3.37. The stock’s fifty day moving average price is C$0.58 and its two-hundred day moving average price is C$0.58. Crescita Therapeutics Inc. has a 52-week low of C$0.36 and a 52-week high of C$0.69.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.